Jim Greenwood, the CEO of the drug industry lobby Biotech Innovation Organization, will step down at the end of 2020, according to Politico.

Charlotte, N.C.-based Premier's ProvideGx program is partnering with Amphastar Pharmaceuticals to supply hospitals with seven drugs in critical shortage.

Michigan's Medicaid program might stop using its contracted, third party pharmacy benefit managers to handle prescription drug claims and price negotiations. Instead the state would manage drug coverage itself, according to a Sept. 30 proposed policy draft.

Californians can now get HIV prevention drugs without a prescription, according to the Los Angeles Times.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Seven drugs had price increases so steep that they cost health insurers and patients $5.1 billion over the course of two years, according to a new study by the Institute for Clinical and Economic Review.

The number of patients who need costly specialty drugs is sharply increasing, according to a recent study by Prime Therapeutics.

Gilead Sciences named Genentech executive Merdad Parsey, MD, PhD, its new CMO, effective Nov. 1.

Pharmaceutical companies in the U.S. are encouraging Mexicans to travel across the border on temporary visas to donate blood plasma in exchange for money, according to ProPublica.

The FDA's approval of the second-ever HIV prevention drug Oct. 3 explicitly excluded women, which some activists and scientists argue sets a dangerous precedent, according to The New York Times.